Highlights
NASDAQ: ARCT       Arcturus Therapeutics Ltd
Last Price Today's Change   Day's Range   Trading Volume
50.71   -1.87 (3.56%)  49.02 - 52.25  313,600

Overview

 
Avg Volume (4 weeks):468,661
4 Weeks Range:39.52 - 57.47
4 Weeks Price Volatility (%):
62.34%
52 Weeks Range:8.51 - 66.24
52 Weeks Price Volatility (%):
73.10%
Average Price Target: 12.00
Price Target Upside/Downside: -38.71

Headlines



No recent Headlines for this stock.


Business Background

Alcobra Ltd is a biopharmaceutical company. It is focused on the development and commercialization of novel treatments for central nervous system and cognitive disorders. The company' s product candidates include Abuse-Deterrent Amphetamine Immediate-Release (ADAIR), a proprietary, abuse-deterrent oral formulation of immediate-release (short-acting) dextroamphetamine for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy; and Metadoxine Extended Release (MDX), a proprietary oral drug for the treatment of ADHD and other cognitive disorders, including Fragile X syndrome. Geographically all the operations are operated through the regions of Israel.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1994  6612  492  172 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MGEN 1.26+0.74 
 TTNP 0.167+0.039 
 GE 7.42+0.32 
 AAPL 111.20-5.40 
 SPY 326.66-11.56 
 SQQQ 24.65+2.59 
 UVXY 23.14+4.07 
 NIO 27.51-0.93 
 XLF 23.61-0.62 
 F 7.70-0.22